Cover Image
市場調查報告書

全球生物可吸收支架市場考察,機會分析,市場佔有率,預測

Global Bioabsorbable Stents Material Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 - 2022

出版商 Occams Business Research & Consulting Pvt. Ltd. 商品編碼 369027
出版日期 內容資訊 英文 140 Pages
商品交期: 請詢問到貨日
價格
Back to Top
全球生物可吸收支架市場考察,機會分析,市場佔有率,預測 Global Bioabsorbable Stents Material Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 - 2022
出版日期: 2016年09月03日 內容資訊: 英文 140 Pages
簡介

全球生物可吸收支架市場在2016年∼2020年間將以年複合成長率 (CAGR) 44.7%的速度成長。

本報告提供全球生物可吸收支架市場相關調查分析,提供您市場概要,市場決策要素,市場區隔,競爭情形,各地區分析,企業簡介等系統性資訊。

第1章 簡介

第2章 市場概要

  • 市場定義和範圍
  • 主要調查結果
  • 參數分析
  • 主要市場考察
  • 競爭情形
  • 五力分析模型
  • 主要的購買標準
  • 策略性建議
  • 策略性結論

第3章 市場決策要素

  • 推動市場要素
  • 阻礙市場要素
  • 市場機會
  • 市場課題
  • 親市場
  • 競爭市場
  • 替代市場

第4章 市場區隔

  • 各吸收速度
  • 各藥物
  • 各用途
  • 各終端用戶
  • 各材料

第5章 各地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 法國
    • 德國
    • 西班牙
    • 義大利
    • 其他
  • 亞太地區
    • 印度
    • 中國
    • 日本
    • 其他
  • 其他地區

第6章 企業簡介

  • ABBOTT LABORATORIES
  • AMARANTH MEDICAL INC.
  • ARTERIAL REMODELING TECHNOLOGIES
  • ARTERIUS LIMITED
  • BOSTON SCIENTIFIC CORP.
  • ELIXIR MEDICAL CORPORATION
  • JOHNSON & JOHNSON
  • 京都醫療設計
  • MEDTRONIC INC
  • MERIL LIFE SCIENCES28
  • SAHAJANAND MEDICAL TECHNOLOGY
  • TEPHA INC
  • XENOGENICS CORPORATION
  • STENTYS S.A.S.
  • BIOABSORBABLE THERAPEUTICS, INC.

圖表

目錄
Product Code: HME-2970916

The global bioabsorbable stents market is expected to grow at the CAGR of 44.7 % during 2016-2022 and is expected to reach around $2800 million by 2022. Stent is a device commonly used for the treatment of blocked arteries. The bioabsorbable stents are tiny & expandable mesh tubes that hold weak and open arteries, helping treat several peripheral and coronary arteries diseases. Bioabsorbable stents are defined as fully biodegradable stents that are completely being absorbed by the human body. The percutaneous coronary intervention, majorly known as angioplasty, is the most effective treatment for peripheral and coronary artery diseases. In this type of procedure, bioabsorbable stents are placed in arteries to keep it open. There has been rising number of angioplasty procedures due to rising cardiovascular diseases, driving the global bioabsorbable stents market. Slow adoption rate of bioabsorbable stents in heart related diseases is one of the major problems being faced by the global market and it also acts as a restraint in the growth of the market.

The global bioabsorbable stents market has been segmented on the basis of absorption rate, drugs, applications, end users, materials and regional outlook. Absorption rate is divided into slow and high absorption segment. Slow absorption rate stents are having maximum market share in 2016 due to the growth is slow absorption provides longer duration of medicines and drugs to release within the artery, which insures efficient healing. Drugs segment is divided into paclitaxel and limos based drugs. Applications segment is divided into coronary and peripheral artery disease. The coronary artery diseases is increasing rapidly due to rising lifestyle related diseases such as obesity, heart attacks, strokes, etc., and increasing number of geriatric population base is also pushing coronary artery diseases upward due to rising application of bioabsorbable stents in coronary artery diseases. End users segment is divided into hospitals and cardiac centers. Hospitals are the major end users of bioabsorbable stents due to rising healthcare quality and infrastructure in hospital and rising heart disease patient's walk-ins in hospitals. Materials segment market is divided into polymeric stents and metallic stents. The magnesium bioabsorbable stents are the most widely used metallic alloy stents in artery related diseases as magnesium is one of the essential elements of the human body. Some of the key opportunities of global bioabsorbable stents market are raising demand from emerging economies and target high risk patients. Presence of substitute and complications with bioabsorbable stent are the major challenge of the market.

Geographically, the bioabsorbable market is divided into North America, Europe, Asia Pacific and rest of the World. North America is dominating with the maximum market share of global bioabsorbable stents market due to rise in awareness about the bioabsorbable stents in the treatment of coronary ailments, rising prevalence of obesity, heart attacks and other cardiac diseases. Dominance of major players in this region is also fueling the global bioabsorbable stents market. United States is contributing the largest market for bioabsorbable stents in North American region, followed by Canada. In European region, Italy, Germany and U.K. are having largest market share of global bioabsorbable stents market. Rising awareness regarding obesity related health issues and increasing health care expenditures are enhancing the global bioabsorbable stents market. During the forecast period, Asia Pacific region has been expected to be high growth due to increase in public awareness related to various peripheral and coronary artery diseases in the region. The contributors such as- India, China and Japan are expected to be the fastest growing bioabsorbable stents markets in Asia Pacific.

Some of the key market players are Abbott Laboratories, Amaranth Medical Inc., Arterial Remodeling Technologies, Arterius Limited, Boston Scientific Corp., Elixir Medical Corporation, Johnson & Johnson, Kyoto Medical Planning Co. Ltd., Medtronic Inc, Meril Life Science, Sahajanand Medical Technologies (part of Sahajanand Group of Companies), Tepha Inc, Xenogenics Corporation (a subsidiary of Multicell Technologies Inc.) and more. The leading players in the global bioabsorbable stents have adopted collaboration, mergers and expansion as the most preferred strategies to increase their product portfolio and expand their respective market presence. Recently on 28th April 2016, Abbott Laboratories has announced the acquisition of St. Jude Medical Inc. This acquisition is a way to bulk up Abbott's medical-devices business to better compete against rivals Medtronic Plc and Boston Scientific Corp. Abbott is also aiming to gain a better negotiating position with its hospital customers, which themselves have become larger and more powerful in recent years.

Table of Contents

1. INTRODUCTION

  • 1.1. EXECUTIVE SUMMARY
  • 1.2. ESTIMATION METHODOLOGY

2. MARKET OVERVIEW

  • 2.1. MARKET DEFINITION AND SCOPE
  • 2.2. KEY FINDINGS
  • 2.3. PARAMETRIC ANALYSIS
    • 2.3.1. PRODUCTION GEOGRAPHICALLY
    • 2.3.2. PRICE VARIATION IN BIOABSORBABLE Stents
  • 2.4. KEY MARKET INSIGHTS
    • 2.4.1. TOP EMERGING COUNTRIES
    • 2.4.2. TOP REVENUE GENERATING SEGMENTS
    • 2.4.3. TOP GROWING MARKETS AND EMERGING TRENDS
    • 2.4.4. TOP GEOGRAPHY
  • 2.5. COMPETITIVE LANDSCAPE
    • 2.5.1. MARKET SHARE ANALYSIS
    • 2.5.2. TOP WINNING STRATEGIES
    • 2.5.3. CASE STUDIES: TOP COMPETITIVE MOVES
  • 2.6. PORTER'S FIVE FORCE MODEL
    • 2.6.1. THREAT OF NEW ENTRANTS
    • 2.6.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
    • 2.6.3. BARGAINING POWER OF BUYER
    • 2.6.4. BARGAINING POWER OF SUPPLIER
    • 2.6.5. INTENSITY OF COMPETITIVE RIVALRY
  • 2.7. KEY BUYING CRITERIA
  • 2.8. STRATEGIC RECOMMENDATION
  • 2.9. STRATEGIC CONCLUSIONS

3. MARKET DETERMINANTS

  • 3.1. MARKET DRIVERS
    • 3.1.1. INCREASING GROWTH OF GERIATRIC POPULATION
    • 3.1.2. INCREASING RISK OF CORONARY ARTERY & PERIPHERAL ARTERY DISEASES IN THE ELDERLY POPULATION
    • 3.1.3. INCREASING NBUMBER OF HEART FAILURE AND DIABETES CASES
    • 3.1.4. STRONG PRODUCT PIPELINES
    • 3.1.5. RISING TECHNOLOGICAL ADVANCEMENTS
  • 3.2. MARKET RESTRAINTS
    • 3.2.1. SLOW ADOPTION RATE
    • 3.2.2. STRINGENT GOVERNMENT REGULATIONS
    • 3.2.3. HIGH COST OF DEVICES
  • 3.3. MARKET OPPORTUNITIES
    • 3.3.1. RISING DEMAND FROM EMERGING ECONOMIES FOR THE MARKET PLAYERS
    • 3.3.2. TARGET HIGH RISK PATIENTS
    • 3.3.3. RISING HEALTHCARE EXPENDITURE IN THE EMERGING COUNTRIES
  • 3.4. MARKET CHALLENGES
    • 3.4.1. AVAILIBILITY OF SUBSTITUTE
    • 3.4.2. INCREASING R&D ACTIVITIES FOR THE CELL TRANSPLANTATION TO TREAT THE HEART DIASEASE
    • 3.4.3. COMPLICATIONS WITH BIOABSORBABLE STENTS
  • 3.5. PARENT MARKET
  • 3.6. COMPETITORS MARKET
  • 3.7. ALTERNATIVE MARKET

4. MARKET SEGMENTATION

  • 4.1. GLOBAL BIOABSORBABLE STENTS MARKET BY ABSORPTION RATE 2014-2022 ($ MILLION)
    • 4.1.1. GLOBAL BIOABSORBABLE STENTS MARKET BY SLOW ABSORPTION STENTS 2012-2022 ($ MILLION)
    • 4.1.2. GLOBAL BIOABSORBABLE STENTS MARKET BY HIGH ABSORPTION STENTS 2012-2022 ($ MILLION)
  • 4.2. GLOBAL BIOABSORBABLE STENTS MARKET BY DRUGS 2014-2022 ($ MILLION)
    • 4.2.1. GLOBAL BIOABSORBABLE STENTS MARKET BY PACLITAXEL 2012-2022 ($ MILLION)
    • 4.2.2. GLOBAL BIOABSORBABLE STENTS MARKET BY LIMUS BASED DRUGS 2012-2022 ($ MILLION)
  • 4.3. GLOBAL BIOABSORBABLE STENTS MARKET BY APPLICATIONS 2014-2022 ($ MILLION)
    • 4.3.1. GLOBAL BIOABSORBABLE STENTS MARKET BY CORONARY ARTERY DISEASE 2012-2022 ($ MILLION)
    • 4.3.2. GLOBAL BIOABSORBABLE STENTS MARKET BY PERIPHERAL ARTERY DISEASE 2012-2022 ($ MILLION)
  • 4.4. GLOBAL BIOABSORBABLE STENTS MARKET BY END USERS 2014-2022 ($ MILLION)
    • 4.4.1. GLOBAL BIOABSORBABLE STENTS MARKET BY HOSPITALS 2012-2022 ($ MILLION)
    • 4.4.2. GLOBAL BIOABSORBABLE STENTS MARKET BY CARDIAC CENTERS 2012-2022 ($ MILLION)
  • 4.5. GLOBAL BIOABSORBABLE STENTS MARKET BY MATERIALS 2014-2022 ($ MILLION)
    • 4.5.1. GLOBAL BIOABSORBABLE STENTS MARKET BY POLYMERIC STENTS 2012-2022 ($ MILLION)
    • 4.5.2. GLOBAL BIOABSORBABLE STENTS MARKET BY METALLIC STENTS 2012-2022 ($ MILLION)

5. GEOGRAPHICAL ANALYSIS

  • 5.1. NORTH AMERICA BIOABSORBABLE STENTS MARKET 2014-2022 ($ MILLION)
    • 5.1.1. UNITED STATES (U.S.) BIOABSORBABLE STENTS MARKET 2014-2022 ($ MILLION)
    • 5.1.2. CANADA BIOABSORBABLE STENTS MARKET 2014-2022 ($ MILLION)
  • 5.2. EUROPE BIOABSORBABLE STENTS MARKET 2014-2022 ($ MILLION)
    • 5.2.1. UNITED KINGDOM (UK) BIOABSORBABLE STENTS MARKET 2014-2022 ($ MILLION)
    • 5.2.2. FRANCE BIOABSORBABLE STENTS MARKET 2014-2022 ($ MILLION)
    • 5.2.3. GERMANY BIOABSORBABLE STENTS MARKET 2014-2022($ MILLION)
    • 5.2.4. SPAIN BIOABSORBABLE STENTS MARKET 2014-2022 ($ MILLION)
    • 5.2.5. ITALY BIOABSORBABLE STENTS MARKET 2014-2022 ($ MILLION)
    • 5.2.6. ROE BIOABSORBABLE STENTS MARKET 2014-2022 ($ MILLION)
  • 5.3. ASIA PACIFIC BIOABSORBABLE STENTS MARKET 2014-2022 ($ MILLION)
    • 5.3.1. INDIA BIOABSORBABLE STENTS MARKET 2014-2022($ MILLION)
    • 5.3.2. CHINA BIOABSORBABLE STENTS MARKET 2014-2022 ($ MILLION)
    • 5.3.3. JAPAN BIOABSORBABLE STENTS MARKET 2014-2022 ($ MILLION)
    • 5.3.4. ROAPAC BIOABSORBABLE STENTS MARKET 2014-2022 ($ MILLION)
  • 5.4. REST OF THE WORLD BIOABSORBABLE STENTS MARKET2014-2022 ($ MILLION)
    • 5.4.1. LATIN AMERICA BIOABSORBABLE STENTS MARKET2014-2022 ($ MILLION)
    • 5.4.2. MENA BIOABSORBABLE STENTS MARKET 2014-2022($ MILLION)
    • 5.4.3. AFRICA BIOABSORBABLE STENTS MARKET 2014-2022 ($ MILLION)

6. COMPANY PROFILE

  • 1. ABBOTT LABORATORIES
  • 2. AMARANTH MEDICAL INC.
  • 3. ARTERIAL REMODELING TECHNOLOGIES
  • 4. ARTERIUS LIMITED
  • 5. BOSTON SCIENTIFIC CORP.
  • 6. ELIXIR MEDICAL CORPORATION
  • 7. JOHNSON & JOHNSON
  • 8. KYOTO MEDICAL PLANNING CO. LTD.
  • 9. MEDTRONIC INC
  • 10. MERIL LIFE SCIENCES28
  • 11. SAHAJANAND MEDICAL TECHNOLOGY (PART OF SAHAJANAND GROUP OF COMPANIES)
  • 12. TEPHA INC
  • 13. XENOGENICS CORPORATION (A SUBSIDIARY OF MULTICELL TECHNOLOGIES INC.)
  • 14. STENTYS S.A.S.
  • 15. BIOABSORBABLE THERAPEUTICS, INC.

LIST OF TABLES

  • 1. GLOBAL BIOABSORBABLE STENTS MARKET BY ABSORPTION RATE 2014-2022 ($ MILLION)
  • 2. GLOBAL BIOABSORBABLE STENTS MARKET BY DRUGS 2014-2022 ($ MILLION)
  • 3. GLOBAL BIOABSORBABLE STENTS MARKET BY APPLICATIONS 2014-2022 ($ MILLION)
  • 4. GLOBAL BIOABSORBABLE STENTS MARKET BY END USERS 2014-2022 ($ MILLION)
  • 5. GLOBAL BIOABSORBABLE STENTS MARKET BY MATERIALS 2014-2022 ($ MILLION)
  • 6. GLOBAL BIOABSORBABLE STENTS MARKET BY REGIONS 2012-2022 ($ MILLION)
  • 7. NORTH AMERICA BIOABSORBABLE STENTS MARKET 2014-2022($ MILLION)
  • 8. UNITED STATES (U.S.) BIOABSORBABLE STENTS MARKET 2014-2022 ($ MILLION)
  • 9. CANADA BIOABSORBABLE STENTS MARKET 2014-2022 ($ MILLION)
  • 10. EUROPE BIOABSORBABLE STENTS MARKET 2014-2022($ MILLION)
  • 11. UNITED KINGDOM (UK) BIOABSORBABLE STENTS MARKET 2014-2022 ($MILLION)
  • 12. FRANCE BIOABSORBABLE STENTS MARKET2014-2022 ($ MILLION)
  • 13. GERMANY BIOABSORBABLE STENTS MARKET 2014-2022 ($ MILLION)
  • 14. SPAIN BIOABSORBABLE STENTS MARKET 2014-2022 ($ MILLION)
  • 15. ITALY BIOABSORBABLE STENTS MARKET 2014-2022 ($ MILLION)
  • 16. ROE BIOABSORBABLE STENTS MARKET 2014-2022 ($ MILLION)
  • 17. ASIA PACIFIC BIOABSORBABLE STENTS MARKET 2014-2022 ($ MILLION)
  • 18. INDIA BIOABSORBABLE STENTS MARKET 2014-2022 ($ MILLION)
  • 19. CHINA BIOABSORBABLE STENTS MARKET 2014-2022 ($ MILLION)
  • 20. JAPAN BIOABSORBABLE STENTS MARKET 2014-2022 ($ MILLION)
  • 21. ROAPAC BIOABSORBABLE STENTS MARKET2014-2022 ($ MILLION)
  • 22. REST OF THE WORLD BIOABSORBABLE STENTS MARKET 2014-2022 ($ MILLION)
  • 23. LATIN AMERICA BIOABSORBABLE STENTS MARKET 2014-2022($ MILLION)
  • 24. MENA BIOABSORBABLE STENTS MARKET 2014-2022 ($ MILLION)
  • 25. AFRICA BIOABSORBABLE STENTS MARKET2014-2022 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL BIOABSORBABLE STENTS MARKET BY SLOW ABSORPTION STENTS 2012-2022 ($ MILLION)
  • 2. GLOBAL BIOABSORBABLE STENTS MARKET BY HIGH ABSORPTION STENTS 2012-2022 ($ MILLION)
  • 3. GLOBAL BIOABSORBABLE STENTS MARKET BY PACLITAXEL 2012-2022 ($ MILLION)
  • 4. GLOBAL BIOABSORBABLE STENTS MARKET BY LIMUS BASED DRUGS 2012-2022 ($ MILLION)
  • 5. GLOBAL BIOABSORBABLE STENTS MARKET BY CORONARY ARTERY DISEASE 2012-2022 ($ MILLION)
  • 6. GLOBAL BIOABSORBABLE STENTS MARKET BY PERIPHERAL ARTERY DISEASE 2012-2022 ($ MILLION)
  • 7. GLOBAL BIOABSORBABLE STENTS MARKET BY HOSPITALS 2012-2022 ($ MILLION)
  • 8. GLOBAL BIOABSORBABLE STENTS MARKET BY CARDIAC CENTERS 2012-2022 ($ MILLION)
  • 9. GLOBAL BIOABSORBABLE STENTS MARKET BY POLYMERIC STENTS 2012-2022 ($ MILLION)
  • 10. GLOBAL BIOABSORBABLE STENTS MARKET BY METALLIC STENTS 2012-2022 ($ MILLION)
  • 11. NORTH AMERICA BIOABSORBABLE STENTS MARKET2014-2022 ($ MILLION)
  • 12. UNITED STATES (U.S.) BIOABSORBABLE STENTS MARKET 2014-2022 ($ MILLION)
  • 13. CANADA BIOABSORBABLE STENTS MARKET 2014-2022 ($ MILLION)
  • 14. EUROPE BIOABSORBABLE STENTS MARKET 2014-2022 ($ MILLION)
  • 15. UNITED KINGDOM (UK) BIOABSORBABLE STENTS MARKET 2014-2022 ($ MILLION)
  • 16. FRANCE BIOABSORBABLE STENTS MARKET 2014-2022 ($ MILLION)
  • 17. GERMANY BIOABSORBABLE STENTS MARKET 2014-2022 ($ MILLION)
  • 18. SPAIN BIOABSORBABLE STENTS MARKET 2014-2022 ($ MILLION)
  • 19. ITALY BIOABSORBABLE STENTS MARKET 2014-2022 ($ MILLION)
  • 20. ROE BIOABSORBABLE STENTS MARKET 2014-2022 ($ MILLION)
  • 21. ASIA PACIFIC BIOABSORBABLE STENTS MARKET 2014-2022 ($ MILLION)
  • 22. INDIA BIOABSORBABLE STENTS MARKET 2014-2022 ($ MILLION)
  • 23. CHINA BIOABSORBABLE STENTS MARKET 2014-2022 ($ MILLION)
  • 24. JAPAN BIOABSORBABLE STENTS MARKET 2014-2022 ($ MILLION)
  • 25. ROAPAC BIOABSORBABLE STENTS MARKET 2014-2022 ($ MILLION)
  • 26. REST OF THE WORLD BIOABSORBABLE STENTS MARKET 2014-2022 ($ MILLION)
  • 27. LATIN AMERICA BIOABSORBABLE STENTS MARKET 2014-2022 ($ MILLION)
  • 28. MENA BIOABSORBABLE STENTS MARKET 2014-2022 ($ MILLION)
  • 29. AFRICA BIOABSORBABLE STENTS MARKET 2014-2022 ($ MILLION)
Back to Top